L084-1839 Screening compound: N-methyl-N-(2-{5-[4-(morpholine-4-carbonyl)phenyl]-1,2,4-oxadiazol-3-yl}ethyl)cyclopropanecarboxamide

L084-1839 Screening compound: N-methyl-N-(2-{5-[4-(morpholine-4-carbonyl)phenyl]-1,2,4-oxadiazol-3-yl}ethyl)cyclopropanecarboxamide
L084-1839 Screening compound: N-methyl-N-(2-{5-[4-(morpholine-4-carbonyl)phenyl]-1,2,4-oxadiazol-3-yl}ethyl)cyclopropanecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L084-1839
N-methyl-N-(2-{5-[4-(morpholine-4-carbonyl)phenyl]-1,2,4-oxadiazol-3-yl}ethyl)cyclopropanecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L084-1839

Molecular Formula

C20H24N4O4 (C20 H24 N4 O4)

Compound Name

N-methyl-N-(2-{5-[4-(morpholine-4-carbonyl)phenyl]-1,2,4-oxadiazol-3-yl}ethyl)cyclopropanecarboxamide

IUPAC name

N-methyl-N-(2-{5-[4-(morpholine-4-carbonyl)phenyl]-124-oxadiazol-3-yl}ethyl)cyclopropanecarboxamide

SMILES

CN(CCc1noc(-c(cc2)ccc2C(N2CCOCC2)=O)n1)C(C1CC1)=O

InChI

InChI=1S/C20H24N4O4/c1-23(19(25)15-6-7-15)9-8-17-21-18(28-22-17)14-2-4-16(5-3-14)20(26)24-10-12-27-13-11-24/h2-5,15H,6-13H2,1H3

InChI Key

SFCQIZQUUQSJLE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27229807

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

384.44

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.173

Distribution Coefficient, logD

1.173

Water Solubility, LogSw

-1.82

Polar Surface Area

74.115

Acid Dissociation Constant (pKa)

22.07

Base Dissociation Constant (pKb)

1.28

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

50.00

L084-1839 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

PI3K-Targeted Library (17255 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L084-1839 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L084-1839?
Check Price and Availability of L084-1839, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L084-1839 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L084-1839
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L084-1839
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L084-1839 available by request